EVER 241220 30.00C (EVER241220C30000) Stock Options, News & Quotes

US OptionsDetailed Quotes

EVER241220C30000

Watchlist

0.15
0.000.00%

15min DelayClose Nov 22 16:00 ET

0.00High0.00Low

Intraday

5D
Daily

News

Earnings Estimates Moving Higher for EverQuote (EVER): Time to Buy?
Zacks Nov 22 11:30 ET
Zacks.com Featured Highlights Include Casey's, EMCOR, EverQuote and Sprouts Farmers Market
Zacks Nov 15 06:00 ET
Do Options Traders Know Something About EverQuote (EVER) Stock We Don't?
Zacks Nov 11 15:35 ET
EverQuote to Participate in Upcoming Investor Conferences
GlobeNewswireNov 7 16:10 ET
EverQuote, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
Yahoo FinanceNov 7 07:20 ET
EverQuote (NASDAQ:EVER) Is Experiencing Growth In Returns On Capital
Yahoo FinanceNov 6 06:00 ET

Comments

Moomoo AI

Jan 30 13:50

Investors are ignoring EverQuote's limited growth expectations, paying for exposure despite the risk. The predicted future revenues may not support a positive sentiment for long, placing investments at risk.

Risks To Shareholder Returns Are Elevated At These Prices For EverQuote, Inc. (NASDAQ:EVER)

Moomoo AI

Dec 3, 2023 06:53

Insider sale below current stock price suggests they see this as a fair value, a potential negative signal. Ownership shows alignment between management and small shareholders, but past sales warn caution before buying.

Have EverQuote Insiders Been Selling Stock?

Moomoo AI

Nov 30, 2023 09:57

B Riley Securities has upgraded EVER and QNST to Buy from Neutral, based on optimism about auto insurance recovery and EverQuote's cost-cutting measures, and decision to focus on core competency by leaving health insurance.

EverQuote, QuinStreet Gain as B Riley Upgrades Eyeing Likely 2024 Auto Insurance Recovery

Moomoo Breakfast US

May 3, 2022 07:23

Columns Today's pre-market stock movers: BP, CHGG, PFE, EL and more

Gainers:
• $Belite Bio (BLTE.US)$ +17.49% (announces that LBS-008 an orally administered tablet has been granted Fast Track Designation by the U.S. Food and Drug Administration for the treatment of STGD1)
• $Atkore (ATKR.US)$ +12.11% (earnings reports)
• $AST SpaceMobile (ASTS.US)$ +9.30% (receives experimental license from FCC for BlueWalker 3 satellite testing)
• $Harmonic (HLIT.US)$ +7.56% (earnings reports)
• $The Chemours (CC.US)$ +7.2% ...

Analysts Notebook

May 3, 2022 05:48

Columns Top upgrades and downgrades on 5/3

Upgrades
• $Agora (API.US)$ : Morgan Stanley Upgrades to Overweight from Equalweight - PT $12.50
• $argenx SE (ARGX.US)$ : Morgan Stanley Upgrades to Overweight from Equalweight - PT $375 (from $278)
• $Idacorp (IDA.US)$ : Wells Fargo Upgrades to Equal Weight from Underweight - PT $110 (from $108)
• $Jakks Pacific (JAKK.US)$ : BMO Capital Upgrades to Outperform from Market Perform - PT $21
• $Coca-Cola FEMSA (KOF.US)$ : Barclays Upgrades to Overweight from Equal Wei...